Home › Stocks › CTXR › All Fund Holders
CTXR — CITIUS PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 29 · Reported value held: $998.12K
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 199.26K | $154.82K | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 215.54K | $130.30K | 0.00% | Reduce |
| Millennium Management history | Q4 2024 | 32.32K | $129.28K | 0.00% | Reduce |
| Manulife Financial history | Q1 2022 | 49.56K | $89.00K | 0.00% | Reduce |
| Deutsche Bank AG history | Q1 2024 | 86.43K | $77.79K | 0.00% | Hold |
| Citadel Advisors history | Q2 2026 | 124.91K | $75.51K | 0.00% | Add |
| Invesco Ltd history | Q1 2024 | 56.35K | $50.57K | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 69.85K | $42.22K | 0.00% | Hold |
| Marshall Wace history | Q4 2022 | 50.95K | $40.25K | 0.00% | New |
| Charles Schwab Investment Management history | Q3 2024 | 76.07K | $38.08K | 0.00% | Hold |
| Northern Trust Corp history | Q2 2026 | 62.74K | $37.93K | 0.00% | Add |
| AQR Capital Management history | Q2 2022 | 25.27K | $23.00K | 0.00% | New |
| Goldman Sachs Group history | Q3 2024 | 37.94K | $18.99K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 26.34K | $15.93K | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2024 | 27.05K | $15.79K | 0.00% | New |
| Principal Global Investors history | Q1 2024 | 15.65K | $14.04K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 17.49K | $10.57K | 0.00% | Add |
| Legal & General Investment Management America history | Q1 2024 | 11.67K | $10.43K | 0.00% | Hold |
| Franklin Resources history | Q2 2024 | 14.27K | $8.33K | 0.00% | Hold |
| BNY Mellon history | Q3 2024 | 14.63K | $7.33K | 0.00% | Hold |
| Citigroup Inc history | Q1 2026 | 5.23K | $4.71K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2024 | 3.51K | $2.05K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 1.00K | $605 | 0.00% | New |
| Bank of America Corp history | Q4 2025 | 307 | $238 | 0.00% | Reduce |
| PNC Financial Services history | Q1 2024 | 177 | $159 | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 120 | $69 | 0.00% | New |
| Renaissance Technologies history | Q3 2023 | 89.27K | $61 | 0.00% | Reduce |
| T. Rowe Price Associates history | Q1 2024 | 30.23K | $28 | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 44 | $27 | 0.00% | Reduce |